PL350300A1 - Composition for treating obesity and aesthetic treatment method - Google Patents

Composition for treating obesity and aesthetic treatment method

Info

Publication number
PL350300A1
PL350300A1 PL00350300A PL35030000A PL350300A1 PL 350300 A1 PL350300 A1 PL 350300A1 PL 00350300 A PL00350300 A PL 00350300A PL 35030000 A PL35030000 A PL 35030000A PL 350300 A1 PL350300 A1 PL 350300A1
Authority
PL
Poland
Prior art keywords
composition
treatment method
treating obesity
aesthetic treatment
obesity
Prior art date
Application number
PL00350300A
Inventor
Max Rombi
Original Assignee
Arkopharma Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9540842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL350300(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arkopharma Laboratoires filed Critical Arkopharma Laboratoires
Publication of PL350300A1 publication Critical patent/PL350300A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/18—Extraction of water soluble tea constituents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/22—Drying or concentrating tea extract
    • A23F3/28—Drying or concentrating tea extract by spraying into a gas stream
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

The invention relates to a composition for the treatment of obesity, comprising a catechol-rich extract of green tea, in particular containing from 20% to 50% by mass of catechols expressed as epigallocatechol gallate (EGCG).
PL00350300A 1999-01-14 2000-01-14 Composition for treating obesity and aesthetic treatment method PL350300A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900328A FR2788438B1 (en) 1999-01-14 1999-01-14 COMPOSITION FOR THE TREATMENT OF OBESITY AND AESTHETIC TREATMENT METHOD
PCT/FR2000/000065 WO2000041708A1 (en) 1999-01-14 2000-01-14 Composition for treating obesity and aesthetic treatment method

Publications (1)

Publication Number Publication Date
PL350300A1 true PL350300A1 (en) 2002-12-02

Family

ID=9540842

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00350300A PL350300A1 (en) 1999-01-14 2000-01-14 Composition for treating obesity and aesthetic treatment method

Country Status (18)

Country Link
US (2) US6814986B1 (en)
EP (1) EP1098657B1 (en)
JP (1) JP2002534474A (en)
KR (1) KR100662116B1 (en)
CN (1) CN1339967A (en)
AT (1) ATE220326T1 (en)
AU (1) AU772464B2 (en)
BR (1) BR0007539A (en)
CA (1) CA2323711A1 (en)
DE (1) DE60000259T2 (en)
ES (1) ES2177506T3 (en)
FR (1) FR2788438B1 (en)
IL (1) IL144297A0 (en)
MX (1) MXPA01007191A (en)
PL (1) PL350300A1 (en)
RU (1) RU2242984C2 (en)
WO (1) WO2000041708A1 (en)
ZA (1) ZA200105786B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610749B2 (en) 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
IL146010A0 (en) * 2000-02-18 2002-07-25 Arch Dev Corp Polyhydroxylated benzene-containing compounds
US6485710B2 (en) * 2000-12-27 2002-11-26 Arthur Zuckerman Appetite suppressant toothpaste
US6610277B2 (en) * 2000-12-27 2003-08-26 Arthur Zuckerman Appetite suppressant toothpaste
US20060240125A1 (en) * 2005-04-21 2006-10-26 Astrup Arne V Composition for affecting weight loss
FR2842425B1 (en) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS TO PROMOTE MUSCLE MASS AT DETRIMENT OF FAT MASS
KR100645385B1 (en) * 2005-10-05 2006-11-23 주식회사 안지오랩 Composition for anti-obesity
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
KR100496622B1 (en) * 2002-04-29 2005-06-29 (주) 김형민한약연구소 Alcohol fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof
US20030220351A1 (en) * 2002-05-24 2003-11-27 Gilbert Gonzales Enteric coated caffeine tablet
WO2004016092A1 (en) * 2002-08-14 2004-02-26 Bionutrigen Co., Ltd Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them
CA2408457A1 (en) 2002-10-17 2004-04-17 Ibm Canada Limited-Ibm Canada Limitee Collection and detection of differences of values of expressions/variables when debugging a computer process
US20040096484A1 (en) * 2002-11-19 2004-05-20 Tyrrell David J. Antioxidant-containing wipes and absorbent products for improving skin health
FR2849992B1 (en) 2003-01-17 2007-03-16 Inst Phytoceutic COMPOSITION FOR ORAL ADMINISTRATION CONTAINING CAPSAICINOIDS
EP1744774A4 (en) * 2004-04-30 2009-08-05 New Hc Formulations Ltd Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite
KR100718161B1 (en) * 2004-06-18 2007-05-15 한국식품연구원 Lipase Inhibitor for Anti-obesity and Use
JP2006016367A (en) * 2004-07-05 2006-01-19 Suntory Ltd Lipase inhibitor
CN101010946A (en) * 2004-09-02 2007-08-01 皇家飞利浦电子股份有限公司 Method and appartus for building an electronic program guide based on channel profiles
US20060211649A1 (en) * 2005-03-21 2006-09-21 Eric Marchewitz Use of cytisine for enhancing physical performance
EP1942874B8 (en) 2005-11-04 2013-11-13 InQpharm Group Sdn Bhd Herbal composition for weight management
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
EP2001561A2 (en) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance
BG1005U1 (en) * 2007-01-26 2008-02-29 Стоян ДОЙЧИНОВ Food additive
BG1004U1 (en) * 2007-01-26 2008-02-29 Дойчин ДОЙЧИНОВ Food additive
KR101488172B1 (en) 2007-08-30 2015-01-30 가오 가부시키가이샤 Instant powder drink
CN102170798B (en) 2008-10-03 2013-06-12 西格马食品可变资本有限公司 Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis
AU2009307753A1 (en) * 2008-10-22 2010-04-29 Metaproteomics, Llc Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis
KR20100124519A (en) * 2009-05-19 2010-11-29 (주)아모레퍼시픽 Compositions containing green tea extracts
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
RU2531928C1 (en) * 2013-10-21 2014-10-27 Федеральное государственное бюджетное учреждение "Научный центр клинической и экспериментальной медицины" Сибирского отделения Российской академии медицинских наук (ФГБУ "НЦКЭМ" СО РАМН) Method for correction of gynoid obesity
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
CN107029237B (en) * 2016-02-04 2021-06-25 康建胜 Application of thermogenesis enhancing compound in enhancing thermogenesis of noradrenaline compound induced brown fat cells
CN107638569A (en) * 2016-07-21 2018-01-30 上海聿健生物科技有限公司 Strengthen the methods and applications of brown fat cell heat production efficiency

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (en) * 1983-05-30 1984-12-10 Mitsui Norin Kk Preparation of natural antioxidant
JPS60114158A (en) 1983-11-25 1985-06-20 House Food Ind Co Ltd Production of fried noodle
JPS60114153A (en) * 1983-11-26 1985-06-20 Osaka Chem Lab Lipid-metabolizing food
JP3018013B2 (en) * 1989-10-19 2000-03-13 三井農林株式会社 α-amylase activity inhibitor
JPH03228664A (en) * 1990-02-02 1991-10-09 Meiji Seika Kaisha Ltd Food having function of suppressing lipid digestion and absorption
CH680854A5 (en) * 1990-05-09 1992-11-30 Nestle Sa
JPH0517352A (en) * 1991-07-03 1993-01-26 Mitsui Norin Kk Sucrase activity-inhibiting agent
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JP2598873B2 (en) * 1993-08-25 1997-04-09 株式会社ロッテ Lipase inhibitor and food and drink to which it is added
US5776756A (en) * 1995-08-31 1998-07-07 Toyo Hakko Co., Ltd. Fermentation compositions having superoxide dismutating activity and an antihypertensive agent for treatment of constipation each having the superoxide dismutating activity
JP3259758B2 (en) * 1996-06-21 2002-02-25 東洋精糖株式会社 Food and drink and method for producing the same

Also Published As

Publication number Publication date
AU3053700A (en) 2000-08-01
EP1098657B1 (en) 2002-07-10
US6830765B2 (en) 2004-12-14
US20030104081A1 (en) 2003-06-05
KR20010103739A (en) 2001-11-23
ATE220326T1 (en) 2002-07-15
FR2788438B1 (en) 2003-10-03
CA2323711A1 (en) 2000-07-20
DE60000259D1 (en) 2002-08-14
CN1339967A (en) 2002-03-13
US6814986B1 (en) 2004-11-09
AU772464B2 (en) 2004-04-29
EP1098657A1 (en) 2001-05-16
ZA200105786B (en) 2002-02-27
JP2002534474A (en) 2002-10-15
FR2788438A1 (en) 2000-07-21
WO2000041708A1 (en) 2000-07-20
DE60000259T2 (en) 2004-04-15
IL144297A0 (en) 2002-05-23
BR0007539A (en) 2001-10-16
ES2177506T3 (en) 2002-12-16
KR100662116B1 (en) 2006-12-27
RU2242984C2 (en) 2004-12-27
MXPA01007191A (en) 2003-07-21

Similar Documents

Publication Publication Date Title
PL350300A1 (en) Composition for treating obesity and aesthetic treatment method
MY127247A (en) New pharmaceutical composition
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
WO2002036106A3 (en) Novel medicament compositions based on anticholinergics and corticosteroids
CA2352676A1 (en) Composition and method for treatment of symptoms associated with insufficient estrogen production
KR100352030B1 (en) Gum composition for removing nicotine
GR3036569T3 (en) Process for extraction of polyphenolic compounds of catechin type from plants, the so obtained extract and its use
BG106202A (en) Method of increasing the content of flavonoids and phenolic substances in plants
YU12903A (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
HK1052137A1 (en) Stabilized ascorbic acid solutions.
PL371205A1 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
AU2001293202A1 (en) Process for extracting compounds from plants
DK1207870T3 (en) Pharmaceutical compositions containing N-palmitoylethanolamide and its use
WO2000044344A3 (en) Antioxidant skin care products
EP1464650A3 (en) Novel estrogenic compounds, obtainable by heat treatment of conjugated estrogens in high humidity
MXPA03001536A (en) Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same.
AU3596801A (en) Murraya koenigii extracts for treating asthma
EP1303300A4 (en) Compositions and methods for treatment of candidiasis
EP1038531A3 (en) A composition comprising soybean isoflavones and a method for the production thereof
MXPA03004537A (en) Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases.
IL153637A0 (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
WO2001015777A8 (en) Pulmonary-administration of mineral ascorbates
MXPA03011092A (en) Oral composition comprising an extract from the bark of albizzia myriophylla.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)